Texas A&M Football

Tale of the Tape: No. 16 Texas A&M at No. 8 Notre Dame

In the second of a home-and-home non-conference series, No. 16 Texas A&M ventures to Notre Dame Stadium in Week 3 for a primetime, top-20 showdown with the No. 8 Fighting Irish. Indeed, this matchup includes plenty of early-season College Football Playoff implications.
By TexAgs
September 10, 2025
4.5k Views
Discuss
Story Poster

Matthew Dawson and Luke Evangelist contributed to this article.

University of Notre Dame

Location: South Bend, Indiana
Nickname: Fighting Irish
Mascot: Leprechaun
Colors: Blue and Gold
Enrollment: 13,174
Founded: 1842
Campus Landmarks: Golden Dome & Touchdown Jesus

The stage is set for a top-20 showdown in South Bend between No. 16 Texas A&M and No. 8 Notre Dame in an early-season clash of the titans with massive playoff implications.

To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Luke Evangelist Matthew Dawson Curtis Dickey DeVonta Smith Marcus Freeman Chris Ash Mike Denbrock Tale of the Tape Riley Leonard Xavier Watts Benjamin Morrison
Show All
Howard Cross III Rylie Mills Jack Kiser Jeremiyah Love Jadarian Price Jordan Faison Ashton Craig Al Golden Marty Biagi Boubacar Traore CJ Carr Leonard Moore Christian Gray Eli Raridon Texas A&M at Notre Dame Rueben Owens II Noah Thomas Le'Veon Moss Marcel Reed KC Concepcion Mario Craver Football Texas A&M Notre Dame 2025
SPONSORED BY
BURLEBO
More Football
See All →
No Layups CFB: Jake Crain of Crain & Co. joins show entering Week 4
By David Nuño
Safety Marcus Ratcliffe is playing with more confidence in 2025
By David Nuño
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, September 15)
By Billy Liucci
Nation's leading receiver Mario Craver named AP's Player of the Week
By Richard Zane
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.